Prostate Cancer Diagnosis Pathway Update ESUR 2024
This is the 2024 update with the latest data on this subject. If you are familiar with the material then it's a reinforcement. Otherwise, it's all new - so enjoy and learn. To discuss the benefits of the MRI pathway for early prostate cancer detection To discuss the appropriate selection of men for MRI and biopsy To discuss biopsy yields in men with negative and positive scan results and how to deal with men with indeterminate findings To learn how the risk of cancers is refined by combining MRI findings with PSAD for biopsy decisions To discuss safety protocols when no significant cancer is found but suspicion remains high To highlight strategies for quality control and quality to ensure the diagnostic process

▶︎
ECR 2024 PI-RADS Update - What is next?

▶︎
NanoKnife / Prostate Cancer Webinar with Dr. Carl Capelouto

▶︎
Challenges for MRI in Screening 2025: a NoteBookLM disussion

▶︎
A future with No Prostate Biopsies with Mark Emberton, MD EP 86

▶︎
I Completed Radiation for Prostate Cancer Radiation Recurrence, and Now I Get My Mojo Back

▶︎
Gleason 3+4 Prostate Cancer

▶︎
Active Surveillance: Past, Present, and Future

▶︎
WB-MRI for Cancer Detection (Screening)

▶︎
Surgery or Radiotherapy for Prostate Cancer? Here's What the Evidence Shows

▶︎
Risk Pathway ESUR 2025 NotebookLM Discussion

▶︎
NoteBookLM Discussion of Key Performance Metrics Lecture.

▶︎
Managing an Elevated PSA: Avoiding Unnecessary Prostate Biopsies

▶︎
2025 Radiation & Side Effects For #ProstateCancer | Amar Kishan, MD & Q+A with Mark Moyad, MD #PCRI

▶︎
Gleason Score 6 7 8 9: Where You Sit on the Ladder Matters

▶︎
Surgery vs. Radiation with Dr. Shaakir Hasan - ZERO Prostate Cancer Summit 2022

▶︎
Prostate MRIs in 2025 | #MarkScholzMD #AlexScholz #PCRI #ProstateCancer

▶︎
When Is Radiotherapy Right for Prostate Cancer?

▶︎
Risk Pathway ESUR 2025 Narration

▶︎
Optimal Duration of Hormone Therapy For #ProstateCancer | #MarkScholzMD #AlexScholz #PCRI

▶︎
